Recombinant Human Putative uncharacterized protein UNQ6493/PRO21345 (UNQ6493/PRO21345)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is specifically requested. Advance notification is required for dry ice shipping, and additional charges will apply.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
UNQ6493/PRO21345; Putative uncharacterized protein UNQ6493/PRO21345
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-122
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Homo sapiens (Human)
Target Names
UNQ6493/PRO21345
Target Protein Sequence
MEPWWPRGTG ANAPWVLVAV PPGLFPSLLG ACCTLTSSSW LQPRFWGLGW RVEVGLEGAG GSSQNYQAAL PSFFCLAASP ASRPAIFGIL AAEPPSASPQ APWPKPGCAS PHGSHWPSIL IC
Uniprot No.

Q&A

What computational approaches should be used for initial characterization of UNQ6493/PRO21345?

For uncharacterized proteins like UNQ6493/PRO21345, computational prediction serves as the first step toward comprehensive characterization. A multi-method approach is recommended:

  • Disorder prediction using both AlphaFold2 (AF2) and IUPred in parallel

    • AF2 leverages deep learning principles and multiple sequence alignments for structure prediction

    • IUPred employs biophysical principles to identify intrinsically disordered regions

    • Combined analysis increases prediction confidence, as these methods show 79% agreement for long disordered regions

  • Secondary structure prediction using tools like DSSP integrated with Biopython

  • Function prediction through:

    • Sequence homology searches

    • Conserved domain identification

    • Gene ontology term prediction

  • Analysis methodology:

    • For AF2, use pLDDT score threshold of 0.7 (scores below indicate disorder)

    • For IUPred, apply cutoff value of 0.425 (scores above indicate disorder)

    • Cross-validate predictions between methods to identify regions of agreement/disagreement

This integrated approach will help distinguish genuinely disordered regions from potential methodological limitations, as sometimes both methods can disagree with experimental annotations in approximately 15% of cases .

How can experimental validation confirm the predicted features of UNQ6493/PRO21345?

Experimental validation requires a systematic approach combining multiple techniques:

  • Expression confirmation:

    • RNA-seq analysis to verify transcription

    • Western blotting with specific antibodies

    • Mass spectrometry to detect the protein in biological samples

  • Structural validation methodology:

    • Circular Dichroism (CD) spectroscopy for secondary structure assessment

    • Nuclear Magnetic Resonance (NMR) for residue-level structural information

    • X-ray crystallography for atomic-resolution structure (if the protein contains ordered domains)

    • Cryo-electron microscopy for complex assemblies

  • Analysis of experimental discrepancies:

    • Compare results across experimental methods to identify potential artifacts

    • Consider context-dependent behavior and binding-induced transitions that may affect results

    • Verify conformational states under different experimental conditions

Understanding that discrepancies between computational predictions and experimental findings often arise due to "weak experimental support, the presence of intermediate states, or context-dependent behavior, such as binding-induced transitions" can help guide experimental design.

What expression systems are most suitable for recombinant production of UNQ6493/PRO21345?

Selection of an appropriate expression system requires thorough evaluation of protein characteristics:

Expression SystemAdvantagesLimitationsRecommended Use Case
Escherichia coliHigh yield, economical, rapid growthLimited post-translational modificationsFor initial structural studies if the protein lacks complex modifications
Mammalian cells (HEK293, CHO)Native post-translational modifications, proper foldingLower yield, higher cost, longer production timeFor functional studies requiring authentic human protein modifications
Insect cells (Sf9, Sf21)Higher yield than mammalian systems, some post-translational modificationsMore complex than bacterial systems, moderate costBalance between yield and structural authenticity
Cell-free systemsRapid production, tolerance of toxic proteinsLimited scale, higher cost per unitFor rapid screening or proteins toxic to live expression systems

Methodological approach:

  • Analyze the protein sequence for potential challenges:

    • Signal peptides requiring secretion systems

    • Transmembrane domains needing detergent solubilization

    • Potential toxic regions requiring regulated expression

  • Design expression constructs with appropriate tags:

    • N-terminal vs. C-terminal tag placement based on predicted disorder regions

    • Cleavable tags to avoid interference with structure

  • Optimize expression conditions through factorial experimental design:

    • Temperature variation (15-37°C)

    • Induction time optimization

    • Media composition screening

How can researchers differentiate between functional disorder and experimental artifacts in UNQ6493/PRO21345?

Distinguishing genuine functional disorder from experimental artifacts requires a methodical multi-technique approach:

  • Cross-validation methodology:

    • Compare predictions from multiple computational methods (AF2, IUPred)

    • Analyze results from complementary experimental techniques (CD, NMR, SAXS)

    • Perform hydrogen-deuterium exchange mass spectrometry to map solvent accessibility

    • Conduct limited proteolysis experiments to identify flexible regions

  • Context-dependent analysis:

    • Examine the protein under various buffer conditions (pH, ionic strength)

    • Test the effect of potential binding partners on structure

    • Assess temperature dependence of disorder-to-order transitions

  • Comparative analysis with similar proteins:

    • Analyze evolutionary conservation patterns in homologous proteins

    • Compare experimental data with known cases of functional disorder

  • Quantitative assessment methodology:

    • Calculate agreement percentages between prediction methods

    • Create density heatmaps for regions of agreement/disagreement

    • Establish confidence scores based on consensus between methods

Research indicates that discrepancies between prediction methods and experimental annotations often occur in regions with "molten globule and pre-molten globule states" or those undergoing "disorder-to-order transition" , suggesting these should be areas of particular focus in UNQ6493/PRO21345 characterization.

What methodologies can resolve the secondary structure elements in disordered regions of UNQ6493/PRO21345?

Resolving secondary structure elements within disordered regions requires specialized approaches:

  • Nuclear Magnetic Resonance (NMR) spectroscopy methodology:

    • 2D and 3D heteronuclear experiments (HSQC, HNCA, HNCACB)

    • Chemical shift index analysis to identify transient secondary structure

    • Residual dipolar coupling measurements to assess conformational preferences

    • Paramagnetic relaxation enhancement to measure long-range contacts

  • Circular Dichroism spectroscopy approach:

    • Far-UV CD (190-250 nm) for secondary structure content estimation

    • Temperature-dependent CD to assess structural stability

    • CD analysis in the presence of stabilizing agents (osmolytes, binding partners)

  • Computational integration methodology:

    • Secondary structure prediction with disorder-aware algorithms

    • Molecular dynamics simulations to sample conformational space

    • Generation of ensemble models representing the conformational diversity

  • Experimental validation strategy:

    • Mutagenesis of key residues predicted to form transient structures

    • Comparative analysis across experimental conditions

Evidence from the literature suggests that "AF2 tended to predict helical regions with high pLDDT scores within disordered segments, while IUPred had limitations in identifying linker regions" , indicating that these specific structural features require particular attention when characterizing UNQ6493/PRO21345.

How can disorder-to-order transitions in UNQ6493/PRO21345 be experimentally characterized?

Characterizing disorder-to-order transitions requires measuring conformational changes under varying conditions:

  • Identification methodology:

    • Computational prediction of potential binding regions using tools like ANCHOR

    • Conservation analysis to identify functionally relevant disordered segments

    • Prediction of disorder-to-order transition regions using MoRFpred

  • Experimental characterization approach:

    • NMR titration experiments with potential binding partners

    • Time-resolved fluorescence spectroscopy with environment-sensitive probes

    • Single-molecule FRET to detect conformational changes

    • Isothermal titration calorimetry (ITC) to measure binding thermodynamics

  • Condition-dependent analysis:

    • Systematic testing of pH, temperature, and ionic strength effects

    • Examination of crowding agent effects to mimic cellular environment

    • Assessment of post-translational modification impacts on folding

  • Data analysis methodology:

    • Fitting binding data to appropriate models (one-site, sequential, cooperative)

    • Calculation of binding constants and thermodynamic parameters

    • Correlation of structural changes with functional outcomes

What high-throughput methods can identify potential binding partners of UNQ6493/PRO21345?

Identifying interaction partners for uncharacterized proteins requires systematic screening approaches:

  • Affinity-based methods:

    • Affinity purification coupled with mass spectrometry (AP-MS)

      • Express tagged UNQ6493/PRO21345 in relevant cell types

      • Perform pull-down experiments under varying conditions

      • Identify interacting proteins through mass spectrometry

    • Protein microarray screening

      • Probe protein arrays with labeled UNQ6493/PRO21345

      • Perform reverse approach using immobilized UNQ6493/PRO21345

  • Proximity-based methods:

    • BioID or APEX2 proximity labeling

      • Express UNQ6493/PRO21345 fused to biotin ligase or peroxidase

      • Allow in vivo biotinylation of proximal proteins

      • Identify labeled proteins by streptavidin pull-down and MS

    • Crosslinking mass spectrometry (XL-MS)

      • Use chemical crosslinkers of varying lengths

      • Identify crosslinked peptides by specialized MS analysis

  • Functional screening methodology:

    • Yeast two-hybrid screening

    • CRISPR-based genetic interaction screens

    • Phenotypic screening of knockout/knockdown libraries

  • Computational prediction integration:

    • Structure-based docking if structural models are available

    • Sequence-based interaction prediction (conserved binding motifs)

  • Validation methodology:

    • Co-immunoprecipitation of endogenous proteins

    • Surface plasmon resonance for binding kinetics

    • Fluorescence polarization for direct binding assays

This comprehensive approach reflects understanding that proteins often function through "interactions with other proteins and non-proteinaceous molecules to control complex processes in cells" .

How can researchers assess if UNQ6493/PRO21345 contains functional linker regions?

Flexible linker regions often have critical functional roles in multi-domain proteins:

  • Computational prediction methodology:

    • Apply specialized linker prediction algorithms

    • Analyze sequence characteristics (glycine/proline content, low hydrophobicity)

    • Compare with known linker regions in related proteins

  • Structural characterization approach:

    • Small-angle X-ray scattering (SAXS) to assess domain arrangement

    • NMR relaxation measurements to identify flexible segments

    • Limited proteolysis to identify accessible cleavage sites

  • Functional analysis methodology:

    • Linker mutation studies (length variation, sequence alteration)

    • Domain isolation and comparison to full-length protein

    • Engineered linker variants to probe flexibility requirements

  • Evolutionary analysis:

    • Conservation pattern analysis (linkers typically show lower conservation)

    • Evaluation of linker length variation across homologs

Research indicates that "linkers in general are better recognized by AF2" than by IUPred, suggesting that AF2 predictions should be given particular weight when analyzing potential linker regions in UNQ6493/PRO21345.

What methodologies can determine if UNQ6493/PRO21345 undergoes post-translational modifications?

Post-translational modifications often regulate protein function, particularly in disordered regions:

  • Computational prediction approach:

    • Prediction of modification sites (phosphorylation, glycosylation, etc.)

    • Analysis of sequence motifs associated with specific modifications

    • Assessment of modification site conservation across species

  • Mass spectrometry methodology:

    • Bottom-up proteomics with enrichment strategies:

      • Phosphopeptide enrichment (TiO₂, IMAC)

      • Glycopeptide enrichment (lectin affinity, hydrazide chemistry)

      • Ubiquitination analysis (K-ε-GG antibody enrichment)

    • Top-down proteomics for intact protein analysis:

      • High-resolution MS to detect mass shifts

      • Electron-transfer dissociation for PTM site localization

    • Targeted MS approaches for specific modification sites

  • Experimental validation approach:

    • Site-directed mutagenesis of predicted modification sites

    • In vitro modification assays with purified enzymes

    • Cell-based assays with modification-specific antibodies

  • Functional impact assessment:

    • Structural analysis of modified vs. unmodified protein

    • Binding studies to determine effects on protein interactions

    • Cellular localization studies of modified variants

Modification TypePrediction ToolsEnrichment MethodDetection TechniqueFunctional Validation
PhosphorylationNetPhos, GPSTiO₂, IMAC, pY-antibodiesLC-MS/MS, Phospho-specific antibodiesPhosphomimetic mutations (S/T→D/E)
GlycosylationNetNGlyc, NetOGlycLectin affinity, HILICLC-MS/MS, Glycosidase treatmentSite-directed mutagenesis (N→Q)
UbiquitinationUbPredK-ε-GG antibodyLC-MS/MSK→R mutations, Ubiquitin pull-down
AcetylationPAIL, GPS-PAILAnti-acetyl-lysine antibodiesLC-MS/MSK→R or K→Q mutations

How can evolutionary analysis inform functional predictions for UNQ6493/PRO21345?

Evolutionary analysis provides crucial insights into protein function when experimental data is limited:

  • Homology identification methodology:

    • PSI-BLAST searches against diverse sequence databases

    • Profile-based searches using HMMer

    • Remote homology detection using structure prediction comparison

  • Multiple sequence alignment approach:

    • Alignment of identified homologs across taxonomic levels

    • Identification of conserved motifs and residues

    • Analysis of co-evolving residue networks

  • Phylogenetic analysis methodology:

    • Construction of phylogenetic trees using maximum likelihood methods

    • Classification of sequences into orthologous groups

    • Analysis of gene duplication and speciation events

  • Conservation pattern interpretation:

    • Mapping conservation scores onto structural models

    • Identification of functional constraints through evolutionary rate analysis

    • Distinguishing between conserved ordered and disordered regions

  • Comparative genomics integration:

    • Analysis of genomic context across species

    • Identification of conserved gene neighborhoods

    • Detection of fusion events with functionally related domains

Research suggests analyzing "ortholog sequences classified into three main evolutionary levels according to the UniProt taxonomic lineage: Vertebrata, Metazoa, and Unicellular" , providing a framework for evolutionary classification of UNQ6493/PRO21345.

What specialized mass spectrometry techniques can enhance structural characterization of UNQ6493/PRO21345?

Advanced mass spectrometry techniques provide unique structural insights for challenging proteins:

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS) methodology:

    • Exchange protocol optimization for UNQ6493/PRO21345

      • Vary pH, temperature, and exchange time

      • Optimize quench conditions and digestion parameters

    • Differential HDX for binding site mapping

    • Analysis of conformational dynamics in solution

  • Cross-linking mass spectrometry (XL-MS) approach:

    • Selection of appropriate crosslinkers based on protein properties

      • Zero-length crosslinkers for direct contacts

      • Variable-length crosslinkers for distance constraints

      • Photo-activatable crosslinkers for non-specific capture

    • MS/MS fragment analysis for crosslink identification

    • Integration with molecular modeling

  • Native mass spectrometry methodology:

    • Buffer optimization for electrospray ionization of intact protein

    • Analysis of oligomeric states and complex formation

    • Ion mobility measurements for conformational assessment

  • Limited proteolysis coupled to MS (LiP-MS):

    • Optimization of proteolysis conditions to probe structural accessibility

    • Identification of protected regions indicating structure

    • Comparison under varying conditions to detect conformational changes

These approaches align with the observation that "mass spectrometry as an analytical technique is used to validate protein characterisation" and can provide crucial insights for challenging uncharacterized proteins.

How can researchers investigate potential disease associations of UNQ6493/PRO21345?

Investigating disease relevance of uncharacterized proteins requires an integrated approach:

  • Genetic association methodology:

    • Analysis of GWAS data for SNPs in or near the encoding gene

    • Examination of rare variants in disease cohorts

    • Assessment of copy number variations affecting the gene

  • Expression analysis approach:

    • Analysis of differential expression in disease tissues

    • Single-cell RNA-seq to identify cell type-specific expression

    • Protein level quantification in patient samples

  • Functional screening methodology:

    • CRISPR knockout/knockdown in disease-relevant cell models

    • Overexpression studies to identify gain-of-function effects

    • Rescue experiments in disease models

  • Structural impact assessment:

    • Analysis of disease-associated variants on predicted structure

    • Effect of mutations on disorder propensity

    • Impact on predicted binding sites or functional motifs

  • Network analysis integration:

    • Placement of UNQ6493/PRO21345 in protein-protein interaction networks

    • Pathway enrichment analysis of interaction partners

    • Co-expression network analysis across disease states

This systematic approach acknowledges that "genome projects have led to the identification of many therapeutic targets, the putative function of the protein, and their interactions" with important implications for disease understanding.

How can researchers overcome solubility challenges when working with UNQ6493/PRO21345?

Addressing solubility issues requires systematic optimization strategies:

  • Construct design methodology:

    • Analysis of hydrophobicity profiles and aggregation-prone regions

    • Design of truncated constructs based on disorder predictions

    • Fusion with solubility-enhancing tags (MBP, SUMO, Trx)

  • Expression condition optimization:

    • Screening of expression temperatures (15-37°C)

    • Co-expression with molecular chaperones

    • Testing of specialized host strains for difficult proteins

  • Buffer optimization approach:

    • Systematic screening of buffer conditions:

      • pH range (typically 5.0-9.0)

      • Salt concentration variations (50-500 mM)

      • Addition of stabilizing agents (glycerol, arginine, trehalose)

    • Detergent screening for proteins with hydrophobic regions

    • Testing of mixed micelle systems for membrane-associated regions

  • Refolding methodology (if necessary):

    • Inclusion body isolation and purification

    • Screening of refolding conditions using fractional factorial design

    • Step-wise dialysis for controlled refolding

This approach recognizes that "understanding the biological systems through a systems-wide study of proteins and their interactions with other proteins and non-proteinaceous molecules" requires obtaining properly folded, soluble protein samples.

What statistical approaches should be used when analyzing experimental data for UNQ6493/PRO21345?

Robust statistical analysis is essential for interpreting experimental results:

  • Experimental design methodology:

    • Power analysis to determine appropriate sample sizes

    • Randomized block designs to control for batch effects

    • Factorial designs to assess interaction effects between variables

  • Data preprocessing approach:

    • Outlier detection and handling methods

    • Normalization techniques appropriate to data type

    • Missing data imputation when necessary

  • Statistical testing methodology:

    • Parametric vs. non-parametric test selection based on data distribution

    • Multiple testing correction (Bonferroni, Benjamini-Hochberg)

    • Effect size calculation in addition to p-values

  • Machine learning integration:

    • Supervised learning for prediction models

    • Unsupervised learning for pattern detection

    • Cross-validation strategies to assess model robustness

  • Interpretation framework:

    • Confidence interval reporting alongside point estimates

    • Sensitivity analysis to assess result robustness

    • Meta-analysis techniques when combining multiple experiments

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.